Purpose: The presence of different polymorphic or pseudo-polymorphic forms in active pharmaceutical ingredients may affect the performance of the formulated products. Pseudo-polymorphs, especially hydrates, present a differential dissolution rate. In such a scenario, pseudo-polymorphism should be strictly controlled due to its impact on the bio-availability of formulates products. Methods: In order to determine solid forms of cefadroxil present in commercial capsules, anhydrous and monohydrate pure the solid forms were prepared and fully characterized by optical microscopy, vibrational spectroscopy (middle and near infrared), calorimetric techniques (differential scanning calorimetry and thermogravimetry). Nuclear magnetic resonance was use...
Polymorphism of drugs has been the subject of intense interest in the pharmaceutical industry for ov...
Excipients can cause a considerable challenge when developing a solid form of an active pharmaceutic...
Characterization and monitoring of solid state properties of the active ingredients and excipients a...
Cefadroxil, an oral antimicrobial, presents few techniques optimized for the reduction of solvents a...
Mefenamic Acid (MFA) is a widely-used non-steroidal anti-inflammatory drug. MFA presents four possib...
Herein, we aimed to develop a strategy for evaluating the consistency of pharmaceutically important ...
Active pharmaceutical ingredients (APIs) can exist in various solid state forms including polymorphs...
This paper describes the development and evaluation of a HPLC and UV spectrophotometric methods to q...
Drugs with low water solubility are predisposed to poor and variable oral bioavailability and, there...
More than 50% of active pharmaceutical ingredients (APIs) are crystallized as simple salts, and of t...
Over 50% of active pharmaceutical ingredients (APIs) are crystallized as simple salts, and of these,...
Purpose: To develop a simple, rapid and sensitive high performance liquid chromatography (HPLC) meth...
Crystallization is widely used as a purification method of Active Pharmaceutical Ingredients, APIs. ...
Meloxicam (MLX) is an anti-inflammatory drug susceptible to variations and crystalline transitions. ...
Objective: This study aims to evaluate possible crystalline changes that can occur with MOX under th...
Polymorphism of drugs has been the subject of intense interest in the pharmaceutical industry for ov...
Excipients can cause a considerable challenge when developing a solid form of an active pharmaceutic...
Characterization and monitoring of solid state properties of the active ingredients and excipients a...
Cefadroxil, an oral antimicrobial, presents few techniques optimized for the reduction of solvents a...
Mefenamic Acid (MFA) is a widely-used non-steroidal anti-inflammatory drug. MFA presents four possib...
Herein, we aimed to develop a strategy for evaluating the consistency of pharmaceutically important ...
Active pharmaceutical ingredients (APIs) can exist in various solid state forms including polymorphs...
This paper describes the development and evaluation of a HPLC and UV spectrophotometric methods to q...
Drugs with low water solubility are predisposed to poor and variable oral bioavailability and, there...
More than 50% of active pharmaceutical ingredients (APIs) are crystallized as simple salts, and of t...
Over 50% of active pharmaceutical ingredients (APIs) are crystallized as simple salts, and of these,...
Purpose: To develop a simple, rapid and sensitive high performance liquid chromatography (HPLC) meth...
Crystallization is widely used as a purification method of Active Pharmaceutical Ingredients, APIs. ...
Meloxicam (MLX) is an anti-inflammatory drug susceptible to variations and crystalline transitions. ...
Objective: This study aims to evaluate possible crystalline changes that can occur with MOX under th...
Polymorphism of drugs has been the subject of intense interest in the pharmaceutical industry for ov...
Excipients can cause a considerable challenge when developing a solid form of an active pharmaceutic...
Characterization and monitoring of solid state properties of the active ingredients and excipients a...